CLINICAL_TRIALS
trial_result
· 2019-01-08
Clinical Trial Update: Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects [Phase 2]
Summary
Phase 2 trial assessing safety and immunogenicity of the zoster vaccine GSK1437173A in elderly subjects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Phase 2 | Status: COMPLETED | Results posted: 2019-01-08